Question - Sudden Hearing Loss
AM-111 Granted Fast-Track Designation
Asked 8 years ago Jakob Hansen 480
Auris Medical's AM-111 drug candidate has been granted fast-track designation by the FDA. The drug which is developed for the treatment of acute sudden hearing loss is currently in phase-III trials. The intratympanic therapy is being investigated in two separate trial arms - the topline results from the first treatment arm are expected by the third quarter of 2017. Read the full news release via the link below.
How is Sudden Hearing Loss diagnosed?
What is Sudden Hearing Loss
Sudden Hearing Loss diet. Is there a diet which improves the quality of lif...
Living with Sudden Hearing Loss. How to live with Sudden Hearing Loss?
What is the prevalence of Sudden Hearing Loss?
Sudden Hearing Loss prognosis
Which are the symptoms of Sudden Hearing Loss?
